CoChat

The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative

Open access
WHO World Mental Health Survey Collaborators, Stein, Dan J., Lim, Carmen C. W., Roest, Annelieke M., de Jonge, Peter, Aguilar-Gaxiola, Sergio, Al-Hamzawi, Ali, Alonso, Jordi, Benjet, Corina, Bromet, Evelyn J., Bruffaerts, Ronny, de Girolamo, Giovanni, Florescu, Silvia, Gureje, Oye, Haro, Josep Maria, Harris, Meredith G., He, Yanling, Hinkov, Hristo, Horiguchi, Itsuko, Hu, Chiyi, Karam, Aimee, Karam, Elie G., Lee, Sing, Lepine, Jean-Pierre, Navarro-Mateu, Fernando, Pennell, Beth-Ellen, Piazza, Marina, Posada-Villa, Jose, ten Have, Margreet, Torres, Yolanda, Viana, Maria Carmen, Wojtyniak, Bogdan, Xavier, Miguel, Kessler, Ronald C., Scott, Kate M. · 2017 · BMC Medicine

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 2 of the 10 sources its claims cite were checked for support.

Abstract

BACKGROUND: There is evidence that social anxiety disorder (SAD) is a prevalent and disabling disorder. However, most of the available data on the epidemiology of this condition originate from high income countries in the West. The World Mental Health (WMH) Survey Initiative provides an opportunity to investigate the prevalence, course, impairment, socio-demographic correlates, comorbidity, and treatment of this condition across a range of high, middle, and low income countries in different geographic regions of the world, and to address the question of whether differences in SAD merely reflect differences in threshold for diagnosis. METHODS: Data from 28 community surveys in the WMH Survey Initiative, with 142,405 respondents, were analyzed. We assessed the 30-day, 12-month, and lifetime prevalence of SAD, age of onset, and severity of role impairment associated with SAD, across countries. In addition, we investigated socio-demographic correlates of SAD, comorbidity of SAD with other mental disorders, and treatment of SAD in the combined sample. Cross-tabulations were used to calculate prevalence, impairment, comorbidity, and treatment. Survival analysis was used to estimate age of onset, and logistic regression and survival analyses were used to examine socio-demographic correlates. RESULTS: SAD 30-day, 12-month, and lifetime prevalence estimates are 1.3, 2.4, and 4.0% across all countries. SAD prevalence rates are lowest in low/lower-middle income countries and in the African and Eastern Mediterranean regions, and highest in high income countries and in the Americas and the Western Pacific regions. Age of onset is early across the globe, and persistence is highest in upper-middle income countries, Africa, and the Eastern Mediterranean. There are some differences in domains of severe role impairment by country income level and geographic region, but there are no significant differences across different income level and geographic region in the proportion of respondents with any severe role impairment. Also, across countries SAD is associated with specific socio-demographic features (younger age, female gender, unmarried status, lower education, and lower income) and with similar patterns of comorbidity. Treatment rates for those with any impairment are lowest in low/lower-middle income countries and highest in high income countries. CONCLUSIONS: While differences in SAD prevalence across countries are apparent, we found a number of consistent patterns across the globe, including early age of onset, persistence, impairment in multiple domains, as well as characteristic socio-demographic correlates and associated psychiatric comorbidities. In addition, while there are some differences in the patterns of impairment associated with SAD across the globe, key similarities suggest that the threshold for diagnosis is similar regardless of country income levels or geographic location. Taken together, these cross-national data emphasize the international clinical and public health significance of SAD.

Overview

CoChat Summary

## TL;DR

This WMH cross-national survey study found that social anxiety disorder (SAD) is common worldwide, with 4.0% lifetime, 2.4% 12-month, and 1.3% 30-day prevalence across all countries. Despite cross-national differences in prevalence, the paper reports consistent global patterns of early onset, persistence, impairment, socio-demographic correlates, comorbidity, and treatment access.

## Key findings

  • Across all countries, SAD prevalence was 4.0% lifetime, 2.4% 12-month, and 1.3% 30-day.
  • Average prevalence was highest in high-income countries (5.5% lifetime, 3.1% 12-month, 1.7% 30-day) and lowest in low/lower-middle-income countries (1.6%, 1.0%, 0.5%).
  • Projected lifetime risk for SAD across the globe was 4.4%; the paper describes onset as early, with risk spanning from the mid-late adolescence to the early 40s.
  • Among respondents with 12-month SAD, between one-third and one-half had severe role impairment in at least one domain; 38% of those with 12-month SAD received any treatment in the past 12 months, and treatment among those with any impairment ranged from 18.0% in low/lower-income countries to 44.2% in high-income countries.

## Methods

  • Data came from 28 community surveys in the WMH Survey Initiative, totaling 142,405 respondents, spanning high-, upper-middle-, and low/lower-middle-income countries across multiple world regions.
  • SAD was assessed with the WHO Composite International Diagnostic Interview (CIDI 3.0); impairment was measured with the Sheehan Disability Scale, and treatment use was assessed by self-report of contact with listed providers.
  • Analyses used cross-tabulations for prevalence/impairment/comorbidity/treatment, survival analysis for age of onset and projected lifetime risk, and logistic regression and survival analyses for socio-demographic correlates; weighted clustered data were handled with Taylor series linearization.

## Limitations

  • The paper states that response rates differed widely across surveys, and that some severe cases may have been less likely to participate, especially where treatment was less available.
  • The surveys were not fully uniform: some were metropolitan-only or otherwise non-national, which the paper says may have affected prevalence estimates.
  • The paper notes that the surveys excluded institutionalized patients and people too intoxicated to be interviewed, and that only two African countries were studied, limiting geographic comparisons.
  • The text also makes evident that the SAD measure may under-detect culturally shaped presentations because the CIDI screening stem questions were limited and did not address fear of offending others; this is stated in the discussion as a measurement limitation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12916-017-0889-2

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Age of onset of SAD by country income level
Fig. 1 Age of onset of SAD by country income levelCC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 0 Not valid · 7 Not checked · 54 Own results and interpretations

21 more claims

Create a free account to see all 63 claims and to verify the 8 references still open.

See all claims — free account
  • Probably not a substantial claim. 6
  • It may state two separate claims as one. 35

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 26 references

Research works printed but not linked: 4

  1. Kessler R, Ustun T. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press; 2008.
  2. Pennell B-E, Mneimneh Z, Bowers A, Chardoul S, Welles J, Viana M, Dinkelmann K, Gebler N, Florescu S, He Y, Huang Y, Tomov T, Vilagut G. Implementation of the World Mental Health Surveys Initiative. In: Kessler R, Ustun T, editors. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press; 2008. p. 33–57.
  3. First MB, Spitzer RL, Gibbon M, Williams BJ. Structured Clinical Interview for Axis I DSM-IV Disorders. New York: Biometrics Research, New York State Psychiatric Institute; 1994.
  4. Institute RT. SUDAAN: Professional Software for Survey Data Analysis. Research Triangle Park: Research Triangle Institute; 2002.

Cited by

See all 605

Metadata

Authors
Collaborators, W. W. M. H. S., Stein, D. J., Lim, C. C. W., Roest, A. M., de Jonge, P., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Benjet, C., Bromet, E. J., Bruffaerts, R., de Girolamo, G., Florescu, S., Gureje, O., Haro, J. M., Harris, M. G., He, Y., Hinkov, H., Horiguchi, I., Hu, C., Karam, A., Karam, E. G., Lee, S., Lepine, J.-P., Navarro-Mateu, F., Pennell, B.-E., Piazza, M., Posada-Villa, J., ten Have, M., Torres, Y., Viana, M. C., Wojtyniak, B., Xavier, M., Kessler, R. C., & Scott, K. M.
Affiliations
  • University of Cape Town (ZA)
  • University Medical Center Groningen (NL)
  • University of Al-Qadisiyah (IQ)
  • Universitat Pompeu Fabra (ES)
  • Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz (MX)
  • Stony Brook University (US)
  • Centro San Giovanni di Dio Fatebenefratelli (IT)
  • University College Hospital, Ibadan (NG)
  • The University of Queensland (AU)
  • Shanghai Mental Health Center (CN)
  • National Center of Public Health and Analyses (BG)
  • Shenzhen KangNing Hospital (CN)
  • University of Balamand (LB)
  • Inserm (FR)
  • Universidad Peruana Cayetano Heredia (PE)
  • Universidad CES (CO)
  • Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy (PL)
  • Harvard University (US)
  • University of Otago (NZ)
Corresponding author
Stein, Dan J.
Venue
BMC Medicine
Published
2017-07-31
Volume
15
Issue
1
Pages
143-143
ISSN
1741-7015 (ISSN-L)
OpenAlex
W2741980530
Cited by
520
References
26
Citations by year
2026: 59 · 2025: 86 · 2024: 91 · 2023: 74 · 2022: 51 · 2021: 74 · 2020: 39 · 2019: 33 · 2018: 11 · 2017: 1
FWCI
29.91
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open University of Cape Town (University of Cape Town) (submittedVersion, cc-by)
  • Open University of Cape Town (University of Cape Town) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
  • Greater South Information System
Funders
  • National Institute of Mental Health (R01 MH070884)
  • John D. and Catherine T. MacArthur Foundation
  • Pfizer Foundation
  • U.S. Public Health Service (R13-MH066849, R01-MH069864, R01 DA016558)
  • Fogarty International Center (FIRCA R03-TW006481)
  • Pan American Health Organization
  • Eli Lilly and Company
  • Ortho-McNeil Pharmaceutical Inc.
  • GlaxoSmithKline
  • Bristol-Myers Squibb
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
Keywords
social anxiety disorder, prevalence, age of onset, role impairment, psychiatric comorbidity, treatment rates, sociodemographic correlates, income level, geographic region, diagnostic thresholds, World Mental Health Survey Initiative, low- and middle-income countries, gender differences, education and income, disability burden, access to mental health care
MeSH terms
Phobia, Social, Adolescent, Adult, Africa, Aged, Child, Child, Preschool, Female, Health Surveys, Humans, Income, Male, Middle Aged, Global Health, Comorbidity, Prevalence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. https://app.cochat.ai/papers/10.1186/s12916-017-0889-2
The paper
Collaborators, W. W. M. H. S., Stein, D. J., Lim, C. C. W., Roest, A. M., de Jonge, P., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Benjet, C., Bromet, E. J., Bruffaerts, R., de Girolamo, G., Florescu, S., Gureje, O., Haro, J. M., Harris, M. G., He, Y., Hinkov, H., Horiguchi, I., . . . Scott, K. M. (2017). The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Medicine. https://doi.org/10.1186/s12916-017-0889-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.